Commentary
Open Access

From medical GPT to medical agents: application prospects of the argus agent combined with EIT in bedside monitoring of ARDS

Yu Yao
Yu Yao
Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
,
Xu Mengzhe
Xu Mengzhe
University of Cambridge, Cambridge CB2 1TN, United Kingdom; Suzhou Kaonter Medical Technology Co., Ltd., Suzhou 215300, Jiangsu, China
,
Song Zhenju
Song Zhenju
Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
,
Xu Chengxi
Xu Chengxi
Suzhou Kaonter Medical Technology Co., Ltd., Suzhou 215300, Jiangsu, China
,
Bai Chunxue
Bai Chunxue
cxbai@fudan.edu.cn
Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Respiratory IoT Medical Engineering Technology Research Center, Shanghai 200032, China; Shanghai Institute of Respiratory Diseases, Shanghai 200032, China; AI+Lung Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Author information
Article notes
Funding
 Yu Yao, Master's Degree, Attending Physician; E-mail: yu.yao3@zs-hospital.sh.cn

Corresponding Author: Bai Chunxue, Doctoral Degree, Chief Physician, Professor; E-mail: cxbai@fudan.edu.cn

Received July 25, 2026; Accepted September 18, 2026; Published September 25, 2026
Supported by the Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0529300), the National Natural Science Foundation of China (82570143 and 82170110), the Science and Technology Commission of Shanghai Municipality (20DZ2254400, 21DZ2200600, and 20DZ2261200), the Shanghai Municipal Science and Technology Major Project (ZD2021CY001), and the Shanghai Municipal Key Clinical Specialty (shslczdzk02201).
Commentary
Open Access
From medical GPT to medical agents: application prospects of the argus agent combined with EIT in bedside monitoring of ARDS
Yu Yao
Yu Yao
Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
,
Xu Mengzhe
Xu Mengzhe
University of Cambridge, Cambridge CB2 1TN, United Kingdom; Suzhou Kaonter Medical Technology Co., Ltd., Suzhou 215300, Jiangsu, China
,
Song Zhenju
Song Zhenju
Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
,
Xu Chengxi
Xu Chengxi
Suzhou Kaonter Medical Technology Co., Ltd., Suzhou 215300, Jiangsu, China
,
Bai Chunxue
Bai Chunxue
cxbai@fudan.edu.cn
Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Respiratory IoT Medical Engineering Technology Research Center, Shanghai 200032, China; Shanghai Institute of Respiratory Diseases, Shanghai 200032, China; AI+Lung Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Author information
 Yu Yao, Master's Degree, Attending Physician; E-mail: yu.yao3@zs-hospital.sh.cn

Corresponding Author: Bai Chunxue, Doctoral Degree, Chief Physician, Professor; E-mail: cxbai@fudan.edu.cn

Article notes
Received July 25, 2026; Accepted September 18, 2026; Published September 25, 2026
Funding
Supported by the Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0529300), the National Natural Science Foundation of China (82570143 and 82170110), the Science and Technology Commission of Shanghai Municipality (20DZ2254400, 21DZ2200600, and 20DZ2261200), the Shanghai Municipal Science and Technology Major Project (ZD2021CY001), and the Shanghai Municipal Key Clinical Specialty (shslczdzk02201).
PDF
On This Page
CITE
Accesses: 62

Abstract

Acute respiratory distress syndrome (ARDS) is a common clinical syndrome associated with high mortality in critical care medicine, characterized by marked intrapulmonary spatial heterogeneity; static indices derived from laboratory tests, respiratory mechanics, and conventional imaging cannot continuously capture the dynamic physiological process of regional ventilation-perfusion mismatch. Although electrical impedance tomography (EIT) offers noninvasive, radiation-free, continuous bedside visualization of regional ventilation distribution, a single modality alone cannot fully reflect the dynamic evolution of disease treatment and prognosis. In recent years, medical artificial intelligence has been evolving from medical GPT (generative pre-trained transformer), which is centered on language generation, toward medical agents that integrate multisource perception, rule-based governance, interpretable reasoning, and human-in-the-loop mechanisms. The Argus agent, jointly developed by Zhongshan Hospital, Fudan University and Suzhou Kaonter Medical Technology Co., Ltd., has implemented multisource device connectivity, an ARDS overview dashboard, continuous EIT video and derived-index display, white-box alerts, and a cloud/local report pipeline, providing a medical-agent paradigm for the clinical implementation of spatiotemporal multimodal monitoring. Our analysis suggests that the value of the Argus agent lies not in 'giving automatic answers' but in revealing regional differences, organizing multisource evidence, and supporting explainable decisions. In the future, with the advancement of standardized acquisition, multicenter studies, and lifecycle governance, the Argus agent is expected to evolve from a 'foundational framework for a monitoring-oriented digital twin' into a trustworthy monitoring-oriented digital twin for ARDS.


Key words: medical GPT; medical agent; electrical impedance tomography; acute respiratory distress syndrome; multimodal monitoring; digital twi

Metaverse in Medicine

ISSN: 3006-4236

Volume 3, Issue 3

September 2026

Pages: 147-242

PDF CITE Accesses: 62
Metaverse in Medicine
ISSN: 3006-4236
ZENTIME PUBLISHING CORPORATION LIMITED
On This Page
CITE
On This Page
Abstract